Combination Treatment for PTSD After the WTC Attack

世贸中心袭击后 PTSD 的联合治疗

基本信息

项目摘要

DESCRIPTION (provided by applicant): Posttraumatic Stress Disorder (PTSD) is a prevalent condition with high rates of disability and comorbidity. Recent surveys in the greater New York area suggest that there still thousands of 9/11-related cases of PTSD due to the severe exposure to the World Trade Center Attack. Previous research has shown that both behavior therapy (prolonged exposure) and, more recently, serotonin reuptake inhibitors (SSRIs), are effective for highly chronic PTSD. However, very little is known about treatment response in individuals with PTSD due to a terrorist act of this scale. In addition, no study has specifically examined the combination of these treatments in individuals with PTSD. Controlled trials from both behavior therapy and medication studies suggest that a substantial proportion of individuals with chronic PTSD benefit from treatment but remain symptomatic and functionally impaired. There are no studies to date that systematically investigate the combination of medication treatment with behavior therapy, although this approach is widely recommended in clinical practice. This study would therefore examine the value of providing SSRI treatment simultaneously with behavior therapy. The overarching goal is the study of maximization of treatment response for adults with chronic PTSD. Participants will be 100 adults with World Trade Center Attack related PTSD. All patients will be randomly assigned to receive either 10 sessions of exposure therapy plus paroxetine, or 10 sessions of exposure therapy plus placebo. Major assessments by an independent evaluator blind to randomization status will be conducted at baseline, week 5, and week 10. Responders to treatment will be continued on pill/placebo for an additional 12 weeks with assessments at week 14, week 18, and week 22. Assessments will focus on PTSD symptoms, general functioning, interpersonal problems, and comorbid anxiety and depressive symptoms. This study possesses several strengths. It examines the combination of two cost-effective, validated, complementary treatments in a new population with chronic PTSD (victims of a large scale terrorist attack). It then examines whether benefits remain or even continue to accrue through a maintenance phase. Findings may enhance public health through the study of maximization of treatment response for this serious and common psychiatric disorder.
描述(由申请人提供):创伤后应激障碍(PTSD)是一种普遍存在的疾病,其致残和合并症的发生率很高。最近在大纽约地区的调查表明,由于世贸中心袭击事件的严重影响,仍有数千起与 9/11 相关的创伤后应激障碍 (PTSD) 病例。先前的研究表明,行为疗法(长期暴露)和最近的血清素再摄取抑制剂(SSRI)对高度慢性 PTSD 有效。然而,由于如此规模的恐怖行为,人们对创伤后应激障碍患者的治疗反应知之甚少。此外,还没有研究专门检验这些治疗方法对 PTSD 患者的联合作用。行为疗法和药物研究的对照试验表明,相当一部分慢性创伤后应激障碍患者从治疗中受益,但仍然存在症状和功能受损。迄今为止,还没有研究系统地研究药物治疗与行为疗法的结合,尽管这种方法在临床实践中被广泛推荐。因此,本研究将探讨同时提供 SSRI 治疗和行为疗法的价值。总体目标是研究慢性创伤后应激障碍 (PTSD) 成人治疗反应的最大化。 参与者将是 100 名患有世贸中心袭击相关 PTSD 的成年人。所有患者将被随机分配接受 10 次暴露疗法加帕罗西汀,或 10 次暴露疗法加安慰剂。不知道随机状态的独立评估员将在基线、第 5 周和第 10 周进行主要评估。对治疗有反应的患者将继续服用药物/安慰剂 12 周,并在第 14 周、第 18 周和第 22 周进行评估。评估将侧重于 PTSD 症状、一般功能、人际关系问题以及共病焦虑和抑郁症状。 这项研究有几个优点。它研究了两种具有成本效益、经过验证的补充疗法在患有慢性创伤后应激障碍(PTSD)的新人群(大规模恐怖袭击的受害者)中的组合。然后,它会检查在维护阶段是否仍然存在甚至继续产生效益。通过研究这种严重且常见的精神疾病的治疗反应最大化,研究结果可能会增强公众健康。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RANDALL Dean MARSHALL其他文献

RANDALL Dean MARSHALL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RANDALL Dean MARSHALL', 18)}}的其他基金

Combination Treatment for PTSD After the WTC Attack
世贸中心袭击后 PTSD 的联合治疗
  • 批准号:
    6722409
  • 财政年份:
    2004
  • 资助金额:
    $ 46.6万
  • 项目类别:
Combination Treatment for PTSD After the WTC Attack
世贸中心袭击后 PTSD 的联合治疗
  • 批准号:
    7017821
  • 财政年份:
    2004
  • 资助金额:
    $ 46.6万
  • 项目类别:
PAROXETINE, PROLONGED EXPOSURE, AND BIOLOGY IN PTSD
帕罗西汀、长期接触以及 PTSD 中的生物学
  • 批准号:
    2889888
  • 财政年份:
    1997
  • 资助金额:
    $ 46.6万
  • 项目类别:
PAROXETINE, PROLONGED EXPOSURE, AND BIOLOGY IN PTSD
帕罗西汀、长期接触以及 PTSD 中的生物学
  • 批准号:
    2032913
  • 财政年份:
    1997
  • 资助金额:
    $ 46.6万
  • 项目类别:
PAROXETINE, PROLONGED EXPOSURE, AND BIOLOGY IN PTSD
帕罗西汀、长期接触以及 PTSD 中的生物学
  • 批准号:
    6391331
  • 财政年份:
    1997
  • 资助金额:
    $ 46.6万
  • 项目类别:
PAROXETINE, PROLONGED EXPOSURE, AND BIOLOGY IN PTSD
帕罗西汀、长期接触以及 PTSD 中的生物学
  • 批准号:
    6185747
  • 财政年份:
    1997
  • 资助金额:
    $ 46.6万
  • 项目类别:
PAROXETINE, PROLONGED EXPOSURE, AND BIOLOGY IN PTSD
帕罗西汀、长期接触以及 PTSD 中的生物学
  • 批准号:
    2674480
  • 财政年份:
    1997
  • 资助金额:
    $ 46.6万
  • 项目类别:

相似海外基金

Digital cognitive-behavior therapy for anxiety and depressive disorders: Building an impactful research project from international partnerships and knowledge exchange in primary care
针对焦虑和抑郁症的数字认知行为疗法:通过初级保健领域的国际合作和知识交流建立一个有影响力的研究项目
  • 批准号:
    480808
  • 财政年份:
    2023
  • 资助金额:
    $ 46.6万
  • 项目类别:
    Miscellaneous Programs
Function of cost bias and effect of cognitive behavior therapy on social anxiety in children and adolescents
成本偏差的作用及认知行为治疗对儿童青少年社交焦虑的影响
  • 批准号:
    23K02970
  • 财政年份:
    2023
  • 资助金额:
    $ 46.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Combined Dialectical Behavior Therapy and Digital Cognitive Behavioral Therapy for Insomnia for Adolescents at High Risk for Suicide: A Pilot RCT
辩证行为疗法和数字认知行为疗法相结合治疗自杀高危青少年的失眠:一项试点随机对照试验
  • 批准号:
    10643478
  • 财政年份:
    2023
  • 资助金额:
    $ 46.6万
  • 项目类别:
A Randomized Clinical Trial Comparing Transdiagnostic Behavior Therapy to Disorder-Specific Psychotherapy in the Recovery of Veterans with Social Anxiety Disorder and Comorbid PTSD Symptomatology
一项随机临床试验,比较跨诊断行为疗法与特定障碍心理疗法在患有社交焦虑症和共病 PTSD 症状的退伍军人康复中的作用
  • 批准号:
    10746930
  • 财政年份:
    2023
  • 资助金额:
    $ 46.6万
  • 项目类别:
Reducing suicide risk among aging caregivers of persons with AD/ADRD: Adapting, implementing, and evaluating Dialectical Behavior Therapy skills training interventions.
降低 AD/ADRD 患者老年护理人员的自杀风险:调整、实施和评估辩证行为治疗技能培训干预措施。
  • 批准号:
    10730708
  • 财政年份:
    2023
  • 资助金额:
    $ 46.6万
  • 项目类别:
A Randomized control trial of behavior therapy of tics in Japan. Exploring the behavior model of tics.
日本抽动行为治疗的随机对照试验。
  • 批准号:
    22K13840
  • 财政年份:
    2022
  • 资助金额:
    $ 46.6万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Role of Behavior Therapy Combined with Buprenorphine for the Treatment of Opioid Use Disorder
行为疗法联合丁丙诺啡治疗阿片类药物使用障碍的作用
  • 批准号:
    10440820
  • 财政年份:
    2022
  • 资助金额:
    $ 46.6万
  • 项目类别:
Efficacy of digital cognitive behavior therapy for insomnia for the prevention of perinatal depression
数字认知行为疗法治疗失眠预防围产期抑郁症的疗效
  • 批准号:
    10429841
  • 财政年份:
    2022
  • 资助金额:
    $ 46.6万
  • 项目类别:
Efficacy of digital cognitive behavior therapy for insomnia for the prevention of perinatal depression
数字认知行为疗法治疗失眠预防围产期抑郁症的疗效
  • 批准号:
    10656415
  • 财政年份:
    2022
  • 资助金额:
    $ 46.6万
  • 项目类别:
Efficacy of digital cognitive behavior therapy for insomnia for the prevention of perinatal depression - supplement
数字认知行为疗法治疗失眠预防围产期抑郁症的疗效 - 补充
  • 批准号:
    10794868
  • 财政年份:
    2022
  • 资助金额:
    $ 46.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了